S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
Log in
ASX:PAB

Patrys Limited (PAB.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.01
MA: A$0.01
A$0.01
52-Week Range N/A
Volume250,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.

MarketRank

Overall MarketRank

0.52 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 9692 7222
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$772,844.00
Book ValueA$0.01 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive PAB News and Ratings via Email

Sign-up to receive the latest news and ratings for PAB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Patrys Limited (PAB.AX) (ASX:PAB) Frequently Asked Questions

What stocks does MarketBeat like better than Patrys Limited (PAB.AX)?

Wall Street analysts have given Patrys Limited (PAB.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Patrys Limited (PAB.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Patrys Limited (PAB.AX)'s earnings last quarter?

Patrys Limited (PAB.AX) (ASX:PAB) issued its quarterly earnings data on Wednesday, February, 20th. The company reported $0.00 earnings per share (EPS) for the quarter.
View Patrys Limited (PAB.AX)'s earnings history
.

Who are some of Patrys Limited (PAB.AX)'s key competitors?

What other stocks do shareholders of Patrys Limited (PAB.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Patrys Limited (PAB.AX) investors own include Woolworths Group Limited (WOW.AX) (WOW), Proteomics International Laboratories Limited (PIQ.AX) (PIQ), Insurance Australia Group Limited (IAG.AX) (IAG) and Bendigo and Adelaide Bank Limited (BEN.AX) (BEN).

Who are Patrys Limited (PAB.AX)'s key executives?

Patrys Limited (PAB.AX)'s management team includes the following people:
  • Dr. James A. Campbell B.Sc., Ph.D., MBA, MD, CEO & Exec. Director
  • Ms. Melanie Jaye Leydin C.A., B.Bus, CA, Company Sec. (Age 47, Pay $120k)
  • Dr. Deanne Greenwood B.Sc., GAICD, Ph.D., MBA, VP of Bus. Devel. & Intellectual Property

What is Patrys Limited (PAB.AX)'s stock symbol?

Patrys Limited (PAB.AX) trades on the ASX under the ticker symbol "PAB."

How big of a company is Patrys Limited (PAB.AX)?

Patrys Limited (PAB.AX) has a market capitalization of $0.00 and generates $772,844.00 in revenue each year.

What is Patrys Limited (PAB.AX)'s official website?

The official website for Patrys Limited (PAB.AX) is www.patrys.com.

How can I contact Patrys Limited (PAB.AX)?

The company can be reached via phone at 61 3 9692 7222.

This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.